Orthofix Medical Inc. 8-K

What Happened

• On February 24, 2026, Orthofix Medical Inc. announced its financial results for the fourth quarter and the year ended December 31, 2025 via a news release (furnished as Exhibit 99.1 to the Form 8-K).
• The company also furnished a corporate investor relations presentation dated February 24, 2026 (Exhibit 99.2) and indicated it may use that presentation, in whole or in part and with possible modifications, in presentations to investors, analysts and others during the fiscal year ending December 31, 2025.
• The Form 8-K was signed by Julie Andrews, Chief Financial Officer, on behalf of Orthofix.

Key Details

• Filing date: February 24, 2026 (Form 8-K).
• Subject: Results of operations and financial condition for Q4 and full-year 2025 (news release attached as Exhibit 99.1).
• Investor materials: Corporate investor relations presentation furnished (Exhibit 99.2) and intended for use under Regulation FD in FY 2025.
• Administrative: Inline XBRL cover page (Exhibit 104) included; Form signed by CFO Julie Andrews.

Why It Matters

• The news release contains the company’s reported quarterly and annual results, which investors and analysts use to assess revenue, profitability, and guidance changes — information that can affect valuation and share price.
• The furnished investor presentation provides the company’s messaging and data points it plans to use when communicating with the market, helping investors and analysts interpret the results and update financial models.
• Because the materials were furnished under Regulation FD, the company has broadly disclosed these documents to ensure even access to the information.